Functional properties of ryanodine receptors in hippocampal neurons change during early differentiation in culture

J Neurophysiol. 2002 Sep;88(3):1077-87. doi: 10.1152/jn.2002.88.3.1077.

Abstract

6-((4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl)amino)hexanoic acid ryanodine (BODIPY-ryanodine) binding and Ca(2+) imaging were used to study the properties of ryanodine receptors (RyRs) and cytoplasmic Ca(2+) (Ca) changes in neurons cultured from the embryonic rat hippocampus during the earliest stages of differentiation. Baseline Ca levels declined from 164 +/- 5 (SD) nM at early stages to 70 +/- 4 nM in differentiated neurons. Fluorescent BODIPY-ryanodine binding signals identified activated RyRs in somata, which were eliminated by removal of external Ca(2+) or by blockage of Ca(2+) entry through L-type but not N-type Ca(2+) channels. The GABA synthesis inhibitor 3-mercaptopropionic acid completely abolished ryanodine binding. Caffeine or K(+)-depolarization inhibited the activity of RyRs at very early stages of differentiation but had stimulatory effects at later stages after a network of processes had formed. BayK-8644 stimulated RyRs throughout all regions of all differentiating cells. The results suggest that in differentiating embryonic hippocampal neurons the activity of RyRs is maintained via Ca(2+) entering through L-type Ca(2+) channels. The mode of activation of L-type voltage-gated Ca(2+) channels with either membrane depolarization or specific pharmacological agents affects the coupled activity of RyRs differently as neurons differentiate processes and networks.

MeSH terms

  • 3-Mercaptopropionic Acid / pharmacology
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Animals
  • Caffeine / pharmacology
  • Calcium / metabolism
  • Calcium Channel Agonists / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Cell Differentiation / physiology
  • Cells, Cultured
  • Hippocampus / cytology*
  • Hippocampus / metabolism*
  • Neurons / cytology*
  • Neurons / metabolism*
  • Potassium Chloride / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Ryanodine / antagonists & inhibitors
  • Ryanodine / metabolism
  • Ryanodine Receptor Calcium Release Channel / metabolism*

Substances

  • Calcium Channel Agonists
  • Calcium Channels, L-Type
  • Ryanodine Receptor Calcium Release Channel
  • Ryanodine
  • Caffeine
  • Potassium Chloride
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • 3-Mercaptopropionic Acid
  • Calcium